Two-year follow-up comparing Rezūm therapy versus bipolar transurethral resection of the prostate for treating benign prostatic hyperplasia. A prospective randomized study.
Autor: | Samir M; Ain Shams University, Cairo, Egypt., Elaal AAA; Ain Shams University, Cairo, Egypt., Gad KAS; Military Medical Academy, Heliopolis, Egypt., Basyony MW; Military Medical Academy, Heliopolis, Egypt. |
---|---|
Jazyk: | angličtina |
Zdroj: | International journal of urology : official journal of the Japanese Urological Association [Int J Urol] 2024 May; Vol. 31 (5), pp. 545-550. Date of Electronic Publication: 2024 Jan 30. |
DOI: | 10.1111/iju.15410 |
Abstrakt: | Objective: Comparison of the efficacy and safety of Rezūm therapy and bipolar transurethral resection of prostate (B-TURP) for the management of benign prostatic hyperplasia (BPH) of 50-120 g size. Methods: One hundred patients with BPH who met the inclusion criteria were included and split into two equal groups to undergo Rezūm therapy or B-TURP. The two groups were compared for efficacy using international prostate symptom score (IPSS), quality of life (QoL), maximum urinary flow rate (Q Results: Rezūm significantly ameliorated IPSS from the baseline score by 55.3%, QoL by 50%, Q Conclusions: Rezūm is a minimally invasive procedure that provides significantly improved symptomatic relief of BPH and quality of life with preservation of erectile and ejaculatory functions. However, it is not as effective as B-TURP. (© 2024 The Japanese Urological Association.) |
Databáze: | MEDLINE |
Externí odkaz: |